Comparative Effectiveness of the Customized poly-propylene Semi-rigid Insole and Prefabricated SiliconeHeel Pad in Pain Reduction and Functional Improvement of Patients with Plantar Fasciitis

Comparative Effectiveness of the Customized poly-propylene Semi-rigid Insole and Prefabricated Silicone Heel Pad in Pain Reduction and Functional Improvement of Patients with Plantar Fasciitis, A Clinical Trial Study.

Status

Recruiting

Phases

Phase 2

Study type

Interventional

Source

IRCT

Registry ID

IRCT20191129045542N2

Enrollment

Registered

2022-07-17

Start date

2022-08-04

Completion date

Unknown

Last updated

2022-08-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

plantar fasciitis. Plantar fascial fibromatosis

Interventions

Intervention 1: Intervention group: prefabricated silicone heel pad. Intervention 2: Intervention group: customized semi rigid polypropylene insole.

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: - Sharp, shooting or localized pain in the sole of the foot for at least one month- 18 year-old patients or older.- Tenderness along the posteromedail aspect of the longitudinal arch or medial calcaneal tubercle.- Start-up pain in the morning with ambulation.- Decrease pain after walking

Exclusion criteria

Exclusion criteria: - Any lower extremity injuries including foot and ankle within 6 months.- Stress fracture- Receiving plantar steroid injection within 3 months.- Use of nonsteroidal anti-inflammatory medications within the previous one week.- Use of custom foot orthotics previously.- Other painful foot condition such as bunion, corn, or ingrown toe nail.- Any other lower extremity neuromuscular conditions such as active radiculopathy- Non-ambulatory, non-communicative.-Unable to complete the interview .- Spasticity due to a neurologic disorder.-Previous foot surgery.- Congenital defects of the lower extremity..- Diabetic mellitus

Design outcomes

Primary

Measure	Time frame
Pain reduction and foot functional improvement. Timepoint: Before, 3 and 12 weeks after treatment. Method of measurement: Visual Analog Scale, Foot Function Index.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactLeila Sadat Mohamadi Jahromi

Shiraz University of Medical Sciences

mohamadil.2668@gmail.com+98 937 535 1951

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026